Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies

OBJECTIVE: To assess the efficacy, safety, and tolerability of adjunctive brivaracetam (BRV), a selective, high-affinity ligand for SV2A, for treatment of partial-onset (focal) seizures (POS) in adults. METHODS: Data were pooled from patients (aged 16–80 years) with POS uncontrolled by 1 to 2 antiep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Menachem, Elinor, Mameniškienė, Rūta, Quarato, Pier Paolo, Klein, Pavel, Gamage, Jessica, Schiemann, Jimmy, Johnson, Martin E., Whitesides, John, McDonough, Belinda, Eckhardt, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955277/
https://www.ncbi.nlm.nih.gov/pubmed/27335114
http://dx.doi.org/10.1212/WNL.0000000000002864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955277/
https://www.ncbi.nlm.nih.gov/pubmed/27335114
http://dx.doi.org/10.1212/WNL.0000000000002864

Ejemplares similares